These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5687420)

  • 21. [The therapeutic value of sporiline in mycoses, especially in pityriasis versicolor].
    Calas E
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(4):402-3. PubMed ID: 5963661
    [No Abstract]   [Full Text] [Related]  

  • 22. [Topical application of a 0.1% ciclopiroxolamine solution for the treatment of pityriasis versicolor].
    Corte M; Jung K; Linker U; Martini H; Sapp-Boncelet I; Schulz H
    Mycoses; 1989 Apr; 32(4):200-3. PubMed ID: 2755466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pityriasis versicolor in Greece and its predisposition factors].
    Parisis N; Stratigos J; Marcelou-Kinti U; Capetanakis J
    Hautarzt; 1977 Nov; 28(11):589-92. PubMed ID: 23362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pityriasis versicolor in a 3-month-old boy].
    Ben Said Z; Boussofara L; Saidi W; Ghariani N; Denguezli M; Belajouza C; Nouira R
    Arch Pediatr; 2010 Jul; 17(7):1110-1. PubMed ID: 20466525
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pityriasis versicolor].
    Auffret N
    Rev Prat; 1984 Feb; 34(7):291-3. PubMed ID: 6322278
    [No Abstract]   [Full Text] [Related]  

  • 26. Pityriasis versicolor atrophicans.
    Tellechea O; Cravo M; Brinca A; Robalo-Cordeiro M
    Eur J Dermatol; 2012; 22(2):287-8. PubMed ID: 22361878
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic evaluation of pyrrolnitrin in ointment on dermatophytes and tinea versicolor].
    Macotela Ruíz E; López Martínez R; Lepe Santana G
    Prensa Med Mex; 1974; 39(5-6):294-7. PubMed ID: 4474664
    [No Abstract]   [Full Text] [Related]  

  • 28. Co-localization of Pityriasis versicolor and BT Hansen's disease.
    Narang T; Dogra S; Kaur I
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):206-7. PubMed ID: 16830643
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ketoconazole foaming gel in tinea versicolor (report of 60 cases)].
    el Euch D; Riahi I; Mokni M; Ben Osman A; Mezlini S; Abidi H
    Tunis Med; 1999 Jan; 77(1):38-40. PubMed ID: 10333696
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison between two different regimens of monthly application with bifonazole spray 1% in pityriasis versicolor.
    Hernàndez-Pèrez E
    Int J Dermatol; 1990; 29(6):438-40. PubMed ID: 2397972
    [No Abstract]   [Full Text] [Related]  

  • 31. A study on the therapeutic efficacy of Cassia alata, Linn. leaf extract against Pityriasis versicolor.
    Damodaran S; Venkataraman S
    J Ethnopharmacol; 1994 Mar; 42(1):19-23. PubMed ID: 8046939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and mycological study of pityriasis versicolor.
    Kanta S; Rani R; Chandra J; Bimra DS
    Indian J Dermatol; 1986 Jan; 31(1):17-21. PubMed ID: 3692540
    [No Abstract]   [Full Text] [Related]  

  • 33. Butenafine: an update of its use in superficial mycoses.
    Gupta AK
    Skin Therapy Lett; 2002 Sep; 7(7):1-2, 5. PubMed ID: 12432425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1% sulconazole cream v 2% miconazole cream in the treatment of tinea versicolor. A double-blind, multicenter study.
    Tanenbaum L; Anderson C; Rosenberg MJ; Akers W
    Arch Dermatol; 1984 Feb; 120(2):216-9. PubMed ID: 6364994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of oral treatment with pramiconazole in pityriasis versicolor: a phase II a trial.
    Faergemann J; Ausma J; Vandeplassche L; Borgers M
    Br J Dermatol; 2007 Jun; 156(6):1385-8. PubMed ID: 17535237
    [No Abstract]   [Full Text] [Related]  

  • 36. Pityriasis versicolor prevalence by age and gender.
    Kyriakis KP; Terzoudi S; Palamaras I; Pagana G; Michailides C; Emmanuelides S
    Mycoses; 2006 Nov; 49(6):517-8. PubMed ID: 17022772
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on pityriasis versicolor in Egypt. II. Clinical and therapeutic.
    el-Hefnawi H; el-Gothamy Z; Refai M
    Mykosen; 1971 Oct; 14(10):483-90. PubMed ID: 5110393
    [No Abstract]   [Full Text] [Related]  

  • 38. Confluent and reticulated papillomatosis associated with tinea versicolor in three siblings.
    Stein JA; Shin HT; Chang MW
    Pediatr Dermatol; 2005; 22(4):331-3. PubMed ID: 16060870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pityriasis versicolor in children: a retrospective study of 164 cases].
    Bouassida S; Boudaya S; Ghorbel R; Meziou TJ; Marrekchi S; Turki H; Zahaf A
    Ann Dermatol Venereol; 1998 Sep; 125(9):581-4. PubMed ID: 9805544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of Malassezia furfur subgroups to terbinafine.
    Leeming JP; Sansom JE; Burton JL
    Br J Dermatol; 1997 Nov; 137(5):764-7. PubMed ID: 9415238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.